FDA approves Roche drug for rare type of blood cancer

(Reuters) - Roche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news